Multifaceted intervention to promote beta-blocker use in heart failure

American Heart Journal
Nancy M Allen LaPointeJudith M Kramer

Abstract

Despite a survival benefit and guideline recommendation for beta-blockers in left ventricular systolic dysfunction, beta-blockers are underused in clinical practice. Medical practices with > or = 15 patients with heart failure (HF) in the Duke Databank for Cardiovascular Disease (DDCD) were identified for a prospective, randomized study using a multifaceted intervention to improve beta-blocker use. Intervention practices received provider education, patient education materials, feedback on beta-blocker use of their patients with HF, and access to telephone consultation with an HF expert. The primary outcome was a comparison between intervention and control practices of the proportion of patients with HF self-reporting beta-blocker use on their first routine DDCD follow-up in the postintervention year. A random effects model was used for the analysis. Post intervention, 2631 patients (1701 in 23 intervention practices and 930 in 22 control practices) completed DDCD follow-up. No significant difference in the proportion of patients with HF reporting beta-blocker use was found in the intervention versus control groups (OR 1.16, 95% CI 0.94-1.43, P = .2), although more patients in the intervention group started a beta-blocker than ...Continue Reading

References

Dec 1, 1989·Journal of the American College of Cardiology·E D Frohlich
May 15, 1998·JAMA : the Journal of the American Medical Association·S B SoumeraiF Gobel
Aug 5, 1998·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·M E HulscherR P Grol
Oct 27, 1999·JAMA : the Journal of the American Medical Association·M D CabanaH R Rubin
Nov 11, 1999·Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality·J L Gruber
Nov 14, 2001·Archives of Internal Medicine·D J WhellanC M O'Connor
Mar 12, 2002·JAMA : the Journal of the American Medical Association·Rajendra H MehtaUNKNOWN GAP Steering Committee of the American College of Cardiology
Dec 23, 2003·Journal of General Internal Medicine·William M TierneyFredric D Wolinsky
Mar 17, 2004·The American Journal of Cardiology·Alain G BertoniDavid C Goff
Mar 18, 2004·JAMA : the Journal of the American Medical Association·Christopher O PhillipsHaya R Rubin

❮ Previous
Next ❯

Citations

Apr 25, 2008·Heart Failure Clinics·Adrian F Hernandez, Gregg C Fonarow
Jun 19, 2007·European Journal of Heart Failure·Finn GustafssonUNKNOWN Danish Heart Failure Clinics Network
Sep 26, 2006·American Heart Journal·Jalal K Ghali
Jan 31, 2009·Journal of the American College of Cardiology·Jonathan G Howlett
May 2, 2013·The Cochrane Database of Systematic Reviews·Sabina CicirielloRachelle Buchbinder
Jun 15, 2012·The Cochrane Database of Systematic Reviews·Noah IversAndrew D Oxman
Jul 12, 2016·Deutsches Ärzteblatt International·Susanne UnverzagtRoland Prondzinsky

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.